GGrantIndex
← Leaderboards

Gerd P Pfeifer

Van Andel Research Institute

$23,178,447
Attributed
$24,220,047
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,220,047 · 13

By mechanism

R01$19,599,240 · 10
R37$3,707,682 · 1
R21$913,125 · 2

Top collaborators

Most similar at Van Andel Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsDna MethylationGenesMethylationPatternMutationCpg IslandsEpigenetic ProcessGenome-WideTumorEventGene ExpressionProteinsDna DamageLinkMapsMalignant NeoplasmsDna SequenceMolecularCarcinogenesisIn VivoComplexCytosineIn Vitro

Grant awards (69)

Mechanisms of cancer mutations$482,549
R01 · FY2025 · CA · contact PI
5-methylcytosine oxidation in development and disease$405,460
R01 · FY2025 · AR · contact PI
Mechanisms of cancer mutations$458,421
R01 · FY2024 · CA · contact PI
5-methylcytosine oxidation in development and disease$405,460
R01 · FY2024 · AR · contact PI
Mechanisms of cancer mutations$482,549
R01 · FY2023 · CA · contact PI
DNA hypermethylation in lung tumors$467,261
R01 · FY2023 · CA · contact PI
5-methylcytosine oxidation in development and disease$418,000
R01 · FY2023 · AR · contact PI
DNA hypermethylation in lung tumors$467,261
R01 · FY2022 · CA · contact PI
5-methylcytosine oxidation in development and disease$413,820
R01 · FY2022 · AR · contact PI
DNA hypermethylation in lung tumors$476,797
R01 · FY2021 · CA · contact PI
5-methylcytosine oxidation in development and disease$418,000
R01 · FY2021 · AR · contact PI
DNA hypermethylation in lung tumors$476,797
R01 · FY2020 · CA · contact PI
DNA hypermethylation in lung tumors$476,797
R01 · FY2019 · CA · contact PI
Etheno Adducts in Liver Cancer$200,425
R21 · FY2019 · CA · contact PI
Etheno Adducts in Liver Cancer$247,950
R21 · FY2018 · CA · contact PI
5-hydroxymethylcytosine in human cancer$394,250
R01 · FY2017 · CA · contact PI
5-hydroxymethylcytosine in human cancer$394,250
R01 · FY2016 · CA · contact PI
Epigenomic Modifications in Mammalian Neurogenesis$420,000
R01 · FY2015 · MH
Epigenomic Modifications in Mammalian Neurogenesis$420,000
R01 · FY2014 · MH
5-hydroxymethylcytosine in human cancer$338,142
R01 · FY2014 · CA · contact PI
Epigenomic Modifications in Mammalian Neurogenesis$403,200
R01 · FY2013 · MH
UV damage, repair, and mutagenesis$398,608
R37 · FY2013 · ES · contact PI
Aging and the unstable epigenome$373,190
R01 · FY2013 · AG · contact PI
5-hydroxymethylcytosine in human cancer$327,684
R01 · FY2013 · CA · contact PI
CpG methylation and mutation$266,077
R01 · FY2013 · CA · contact PI
Epigenomic Modifications in Mammalian Neurogenesis$420,000
R01 · FY2012 · MH
UV damage, repair, and mutagenesis$406,742
R37 · FY2012 · ES · contact PI
Aging and the unstable epigenome$394,909
R01 · FY2012 · AG · contact PI
5-hydroxymethylcytosine in human cancer$348,600
R01 · FY2012 · CA · contact PI
CpG methylation and mutation$283,061
R01 · FY2012 · CA · contact PI
Epigenomic Modifications in Mammalian Neurogenesis$420,000
R01 · FY2011 · MH
UV damage, repair, and mutagenesis$406,742
R37 · FY2011 · ES · contact PI
Aging and the unstable epigenome$394,909
R01 · FY2011 · AG · contact PI
CpG methylation and mutation$283,061
R01 · FY2011 · CA · contact PI
Aging and the unstable epigenome$410,850
R01 · FY2010 · AG · contact PI
UV damage, repair, and mutagenesis$410,850
R37 · FY2010 · ES · contact PI
CpG methylation and mutation$291,816
R01 · FY2010 · CA · contact PI
UV damage, repair, and mutagenesis$415,000
R37 · FY2009 · ES · contact PI
Aging and the unstable epigenome$415,000
R01 · FY2009 · AG · contact PI
CpG methylation and mutation$291,816
R01 · FY2009 · CA · contact PI
UV damage, repair, and mutagenesis$319,650
R37 · FY2008 · ES · contact PI
Characterization of MBD3L1 and MBD3L2$300,895
R01 · FY2008 · CA · contact PI
CpG Methylation and Mutation$293,558
R01 · FY2008 · CA · contact PI
DNA methylation in cancer genomes$211,250
R21 · FY2008 · CA · contact PI
UV damage, repair, and mutagenesis$326,174
R37 · FY2007 · ES · contact PI
Characterization of MBD3L1 and MBD3L2$300,895
R01 · FY2007 · CA · contact PI
CpG Methylation and Mutation$293,558
R01 · FY2007 · CA · contact PI
DNA methylation in cancer genomes$253,500
R21 · FY2007 · CA · contact PI
UV damage, repair, and mutagenesis$335,916
R37 · FY2006 · ES · contact PI
Characterization of MBD3L1 and MBD3L2$309,882
R01 · FY2006 · CA · contact PI
CpG Methylation and Mutation$302,324
R01 · FY2006 · CA · contact PI
UV damage, repair, and mutagenesis$344,000
R37 · FY2005 · ES
Characterization of MBD3L1 and MBD3L2$317,340
R01 · FY2005 · CA
RASSF1 Tumor Suppressor Gene$311,500
R01 · FY2005 · CA
CpG Methylation and Mutation$309,600
R01 · FY2005 · CA
UV damage, repair, and mutagenesis$344,000
R37 · FY2004 · ES
Characterization of MBD3L1 and MBD3L2$317,340
R01 · FY2004 · CA
RASSF1 Tumor Suppressor Gene$311,500
R01 · FY2004 · CA
CpG Methylation and Mutation$309,600
R01 · FY2004 · CA
RASSF1 Tumor Suppressor Gene$311,500
R01 · FY2003 · CA
UV DAMAGE, REPAIR AND MUTAGENESIS$275,757
R01 · FY2003 · ES
CPG METHYLATION AND MUTATION$275,625
R01 · FY2003 · CA
RASSF1 Tumor Suppressor Gene$311,500
R01 · FY2002 · CA
CPG METHYLATION AND MUTATION$275,625
R01 · FY2002 · CA
UV DAMAGE, REPAIR AND MUTAGENESIS$267,724
R01 · FY2002 · ES
CPG METHYLATION AND MUTATION$275,625
R01 · FY2001 · CA
UV DAMAGE, REPAIR AND MUTAGENESIS$259,926
R01 · FY2001 · ES
CPG METHYLATION AND MUTATION$275,625
R01 · FY2000 · CA
UV DAMAGE, REPAIR AND MUTAGENESIS$252,354
R01 · FY2000 · ES